| 2021 |
Huang WT, Su TY, Chan MH, Tsai JY, Do YY, Huang PL, (Hsiao M)*, Liu RS, Near-infrared Nanophosphor Embedded in Mesoporous Silica Nanoparticle with High Light-Harvesting Efficiency to Promote Dual Photosystem, ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, vol. Mar 22;60(13):6955, 6959, 2021 |
| 2021 |
Pan JK, Lin CH, Kuo YL, Ger LP, Cheng HC, Yao YC, (Hsiao M, Lu PJ, MiR-211 Determines Brain Metastasis Specificity through SOX11/NGN2 Axis in Triple-negative Breast Cancer, ONCOGENE, vol. Mar;40(9):1737, 1751, 2021 |
| 2021 |
Lin TC, (Hsiao M)*, Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments - [INVITED REVIEW], INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. Mar 11;22(6), 2870, 2021 |
| 2021 |
Yang YC, Chien MH, Lai TC, Tung MC, Jan YH, Chang WM, Jung SM, Chen MH, Yeh CN, (Hsiao M)*, Proteomics-based Identification of TMED9 Is Linked to Vascular Invasion and Poor Prognoses in Patients with Hepatocellular Carcinoma, JOURNAL OF BIOMEDICAL SCIENCE, vol. Apr 22;28(1), 29, 2021 |
| 2021 |
Yuan LT, Lee WJ, Yang YC, Chen BR, Yang CY, Chen MW, Chen JQ, (Hsiao M, Chien MH, Hua KT, Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122, CANCERS, vol. 13(10), 2376, 2021 |
| 2021 |
Chang YC, Chan MH, Li CH, Yang CJ, Tseng YW, Tsai HF, Chiou J, (Hsiao M)*, Metabolic Protein Phosphoglycerate Kinase 1 Confers Lung Cancer Migration by Directly Binding to HIV Tat Specific Factor 1, CELL DEATH DISCOVERY, vol. Jun 5;7(1), 135, 2021 |
| 2021 |
Chan MH, Chen W, Li CH, Fang CY, Chang YC, Wei DH, Liu RS, (Hsiao M)*, An Advanced In Situ Magnetic Resonance Imaging and Ultrasonic Theranostics Nanocomposite Platform: Crossing the Blood–Brain Barrier and Improving the Suppression of Glioblastoma Using Iron-Platinum Nanoparticles in Nanobubbles, ACS APPLIED MATERIALS & INTERFACES, vol. Jun 16;13(23), 26759-26769, 2021 |
| 2021 |
Chung SY, Hung YP, Pan YR, Chang YC, Wu CE, Hsu DS, Chang PM, Lu ML, Huang CY, Su Y, (Hsiao M, Yeh CN, Chen MH, Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway, BIOMEDICINES, vol. 9(8), 885, 2021 |
| 2021 |
Chang YC, Chan MH, Li CH, Fang CY, (Hsiao M)*, Chen CL, Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers [INVITED REVIEW], BIOMEDICINES, vol. 9(8), 931, 2021 |
| 2021 |
Hsu HJ, Tung CP, Yu CM, Chen CY, Chen HS, Huang YC, Tsai PH, Lin SI Peng HP, Chiu YK, Tsou YL, Kuo WY, Jian JW, Hung FH, Hsieh CY, (Hsiao M, Chuang SS, Shen CN, Wang YA, Yang AS, Eradicating Mesothelin-positive Human Gastric and Pancreatic Tumors in Xenograft Models with Optimized Anti-mesothelin Antibody–drug Conjugates from Synthetic Antibody Libraries, SCIENTIFIC REPORTS, vol. 11(1), 15430, 2021 |
| 2021 |
Kuo KT, Yeh CT, Chen TT, Satriyo PB, Wang CH, Wu ATH, Chao TY, Lee KY, (Hsiao M, Wang LS, Bruton’s Tyrosine Kinase (BTK) Mediates Resistance to EGFR Inhibition in Non-Small Cell Lung Cancer, ONCOGENESIS, vol. 10(7), 56, 2021 |
| 2021 |
Chi LH, Wu ATH, (Hsiao M)*, Li YC, A Transcriptomic Analysis of Head and Neck Squamous Cell Carcinomas for Prognostic Indications, JOURNAL OF PERSONALIZED MEDICINE, vol. 11(8), 782, 2021 |
| 2021 |
Li CH, Hsu TI, Chang YC, Chan MH, Lu PJ, (Hsiao M)*, Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis [INVITED REVIEW], BIOMEDICINES, vol. Sep 18;9(9), 1265, 2021 |
| 2021 |
Li CH, Chang YC, Chan MH, Yang YF, Liang SM, (Hsiao M)*, Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives [INVITED REVIEW], BIONMEDICINES, vol. Sep 4;9(9), 1159, 2021 |
| 2021 |
Chen TH, Chen YJ, Huang TS, (Hsiao M, Lin CC, Liu YP, Does Positive Feeling Lead to More Impulsiveness? - Implication of Previous Rewarded Experience on Location-dependent Motoric Impulsivity, CHINESE JOURNAL OF PHYSIOLOGY, vol. 64(5), 218-224, 2021 |
| 2021 |
Wu ATH, Huang HS, Wen YT, Lawal B, Mokgautsi N, Huynh TT, (Hsiao M, Wei L, A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling., CELLS, vol. Sep 11;10(9), 2391, 2021 |
| 2021 |
Tsai HF, Chang YC, Li CH, Chan MH, Chen CL, Tsai WC, (Hsiao M)*, Type V Collagen Alpha 1 Chain Promotes the Malignancy of Glioblastoma through PPRC1-ESM1 Axis Activation and Extracellular Matrix Remodeling, CELL DEATH DISCOVERY, vol. Oct. 26;7(1), 313, 2021 |
| 2021 |
Pai S, Yadav VK, Kuo KT, Pikatan NW, Lin CS, Chien MH, Lee WH, (Hsiao M, Chiu SC, Yeh CT, Tsai JT, PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway., INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. Oct. 25;22(21), 11492, 2021 |
| 2021 |
Chan MH, Lu CN, Chung YL, Chang YC, Li CH, Chen CL, Wei DH, (Hsiao M)*, Magnetically Guided Theranostics: Montmorillonite-based Iron/platinum Nanoparticles for Enhancing In Situ MRI Contrast and Hepatocellular Carcinoma Treatment, JOURNAL OF NANOBIOTECHNOLOGY, vol. Oct 9;19(1), 308, 2021 |
| 2021 |
Yeh YC, Lawal B, (Hsiao M, Huang TH, Huang CF, Identification of NSP3 (SH2D3C) as a Prognostic Biomarker of Tumor Progression and Immune Evasion for Lung Cancer and Evaluation of Organosulfur Compounds from Allium sativum L. as Therapeutic Candidates., BIOMEDICINES, vol. Oct 30;9(11), 1582, 2021 |
| 2021 |
Wen YC, Liu YN, Yeh HL, Chen WH, Jiang KC, Lin SR, Huang J, (Hsiao M, Chen WY*, TCF7L1 Regulates Cytokine Response and Neuroendocrine Differentiation of Prostate Cancer, ONCOGENESIS, vol. Nov 20;10(11), 81, 2021 |
| 2021 |
Lin MY, Chang YC, Wang SY, Yang MH, Chang CH, (Hsiao M, Kitsis RN, Lee YJ, OncomiR miR-182-5p Enhances Radiosensitivity by Inhibiting the Radiation-Induced Antioxidant Effect through SESN2 in Head and Neck Cancer., ANTIOXIDANTS, vol. Nov. 14;10(11), 1808, 2021 |
| 2021 |
Chan MH, Chen BG, Ngo LT, Huang WT, Li CH, Liu RS, (Hsiao M)*, Natural Carbon Nanodots: Toxicity Assessment and Theranostic Biological Application [INVITED REVIEW], PHARMACEUTICS, vol. Nov 5;13(11), 1874, 2021 |
| 2021 |
V. Gannedi, B. Villuri, S. Reddy, C.-C. Ku, C.-H. Wong, S.-C. Hung, Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (S)-P-Phosphoramidation., The Journal of organic chemistry, vol. 86(7), 4977–4985, 2021 |
| 2021 |
S. S. Shivatare, T.-J. Chen, Y.-Y. Cheng, V. S. Shivatare, T.-I. Tsai, H.-Y. Chaung, C.-Y. Wu, C.-H. Wong, Immunogenicity Evaluation of N-Glycans Recognized by HIV Broadly Neutralizing Antibodies., ACS chemical biology, vol. 16(10), 2016-2025, 2021 |
| 2021 |
J.-T. Jan, T.-J. R. Cheng, Y.-P. Juang, H.-H. Ma, Y.-T. Wu, W.-B. Yang, C.-W. Cheng, X. Chen, T.-H. Chou, J.-J. Shie, W.-C. Cheng, R.-J. Chein, S.-S. Mao, P.-H. Liang, C. Ma, S.-C. Hung, C.-H. Wong, Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection., Proceedings of the National Academy of Sciences of the United States of America, vol. 118(5), e2021579118, 2021 |
| 2021 |
C.-W. Lin, Y.-J. Wang, T.-Y. Lai, T.-L. Hsu, S.-Y. Han, H.-C. Wu, C.-N. Shen, V. Dang, M.-W. Chen, L.-B. Chen, C.-H. Wong, Homogeneous antibody and CAR-T cells with improved effector functions targeting SSEA-4 glycan on pancreatic cancer., Proceedings of the National Academy of Sciences of the United States of America, vol. 118(50), e-e2114774118, 2021 |
| 2021 |
R.-H. Lee, Y.-J. Wang, T.-Y. La, T.-L. Hsu, P.-K. Chuang, C.-H. Wong, Combined Effect of Anti-SSEA4 and Anti-Globo H Antibodies on Breast Cancer Cells., ACS chemical biology, vol. 16(8), 1526-1537, 2021 |
| 2021 |
C.-W. Chang, M.-H. Lin, C.-K. Chan, K.-Y. Su, C.-H. Wu, W.-C. Lo, S. Lam, Y.-T. Cheng, P.-H. Liao, C.-H. Wong, C.-C. Wang, Automated Quantification of Hydroxyl Reactivities: Prediction of Glycosylation Reactions., Angewandte Chemie (International ed. in English), vol. DOI: 10.1002/anie.202013909, 2021 |
| 2021 |
Y.-A. Ko, Y.-H. Yu, Y.-F. Wu, Y.-C. Tseng, C.-L. Chen, K.-S. Goh, H.-Y. Liao, T.-H. Chen, T.-J. R. Cheng, A.-S. Yang, C.-H. Wong, C. Ma, K.-I. Lin, A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells., PLoS pathogens, vol. 17(8), e1009724, 2021 |
